drugset / Trial / NCT01175460
S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Patients with advanced esophageal cancer will receive thoracic radiation therapy 60Gy over 30 fractions,and concurrent with s-1 and nedaplatin.
Timeline
- Start
- 2010-01
- Primary completion
- 2011-01
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nedaplatin | Small molecule | 75 mg/m2 | — |
| Subject | S-1 | Small molecule | 60 mg/m2 | — |